Taiwan Biomaterial Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2019
August 11, 2019 at 02:02 pm
Share
Taiwan Biomaterial Co., Ltd. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced sales was TWD 3.555 million compared to TWD 782,000 a year ago. Operating loss was TWD 21.919 million compared to TWD 17.136 million a year ago. Net loss was TWD 21.425 million compared to TWD 13.259 million a year ago. Basic loss per share was TWD 0.69 compared to TWD 0.44 a year ago. For the half year, sales was TWD 3.555 million compared to TWD 816,000 a year ago. Operating loss was TWD 39.338 million compared to TWD 32.809 million a year ago. Net loss was TWD 38.504 million compared to TWD 27.324 million a year ago. Basic loss per share was TWD 1.26 compared to TWD 0.91 a year ago.
Taiwan Biomaterial Co., Ltd. is a Taiwan-based company mainly engaged in provision of medical equipment. The products are still in research and development stage. The Company's subsidiary TAIWAN MEDICAL RAPID PROTOTYPING CO., LTD.(TRP) is engaged in trial production of medical equipment. Main products include foam artificial meninges products, stroke thrombus aspiration catheter products, repair and regeneration products for early degenerative arthritis and others.
TAIWAN BIOMATERIAL CO., LTD. 
